Back to Results
First PageMeta Content
GPC Biotech / Spectrum Pharmaceuticals / HRPC / Satraplatin / Prostate cancer


Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U.S.C. §208(b)(3) and 21 U.S.C. $355 (n)(4) Otis Brawley, M.D. Commi.ttee:
Add to Reading List

Document Date: 2007-07-09 08:23:18


Open Document

File Size: 25,97 KB

Share Result on Facebook

Company

Spectrum Pharmaceuticals / GPC Biotech AG / Johnson Matthey Pharmaceuticals / Johnson Matthey PLC / /

Currency

USD / /

MedicalCondition

prostate cancer / /

MedicalTreatment

chemotherapy / /

Organization

FDA / Oncologic Drugs Advisory Committee / /

Technology

chemotherapy / /

SocialTag